UAE First to Approve Vitiligo Tablets

The UAE became the first country in the world to approve tablets for the treatment of vitiligo.

Consensus

• The UAE became the first country in the world to authorize oral tablets for treating non-segmental vitilago.
• The approved medication is RINVOQ (upadacitinib) and is intended for patients aged 12 years and older.
• The drug is taken once daily and is used for systemic therapy.
• Vitiligo is an autoimmune skin disease where pigment-producing cells die or stop functioning, leading to colorless patches on the skin.
• Prior to this approval, treatment options were limited to topical medications, phototherapy, and laser methods.
• The UAE's regulatory authority, the EDE, made the decision to expand treatment options for vitiligo patients.

Points of divergence

• The EDE emphasized that the approval should accelerate patient access to innovative treatments and recommended consulting specialists for unusual skin color changes. — vedomosti
• In July, Russian scientists developed a radioprotective drug reducing the negative effects of ionizing radiation during radiotherapy. — vedomosti
• The approval marks a breakthrough in treating autoimmune skin diseases in the UAE. — vesti

Coverage (3 sources)

• UAE approved pills for vitiligo treatment first in the world — Ведомости
• UAE first in the world approved tablets for non-segmental vitiligo, newspaper Khaleej Times reported. The drug is permitted for use in... — ТАСС (Telegram)
• UAE first in world to approve vitiligo pills — Вести

Key entities

• UAE
• Khaleej Times
• Moscow
• TASS
• United Arab Emirates
• UAE (EDE)